Company intelligence
Brandsymbol
Global naming and brand strategy with deep pharmaceutical expertise.
About Brandsymbol
Brandsymbol is a global naming and brand consultancy with deep expertise in pharmaceutical and healthcare branding. We also partner with organizations across industries to develop distinctive names, brand strategies and identities that support business growth. Founded in 2010, Brandsymbol was created with one goal: to draw on decades of experience to build a dynamic, fact-driven agency focused on the needs of its clients. We combine strategic, evidence-based insights with exceptional creative thinking to produce world-class branding solutions and strengthen the client-agency relationship. Our team brings together veteran executive leadership and top-tier international talent across naming, strategy, research, linguistics, regulatory review and design. Supported by a sophisticated proprietary process, this diverse expertise allows us to assign the right global branding professionals to every challenge—providing the specialization, flexibility and responsiveness each engagement requires. From complex pharmaceutical naming and global brand development to corporate naming, brand strategy and visual identity, Brandsymbol helps organizations build distinctive, defensible brands with the clarity and confidence to compete. Follow Brandsymbol for practical perspectives on pharmaceutical naming, global brand strategy, regulatory considerations, research, identity and the decisions behind successful brands.
Verified activity
Signals from Brandsymbol
2 published signals
Research & Knowledge
Brandsymbol published an updated FAQ addressing questions pharmaceutical and biotech teams should consider for 2027, including USAN and INN naming conventions, candidate evaluation, and application timing.
Reported by Brandsymbol
Legal & Regulatory
Brandsymbol partners at Takeda received FDA approval for MIMRYLO™, a hepcidin mimetic for adults with polycythemia vera.
Reported by Brandsymbol